# Princeton Bancorp, Inc.: financial statements, quarterly

BPRN · Nasdaq · CIK 1913971 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/bprn.md) · [Financials](/companies/bprn/financials.md) · [Filings](/companies/bprn/filings.md) · [Insiders](/companies/bprn/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/bprn/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Interest expense | $m | [10.3](/filings/0001193125-23-275720.md) | [11.5 d](/filings/0001193125-24-076546.md) | [12.6](/filings/0001193125-24-138317.md) | [13.4](/filings/0001193125-24-198936.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [1.5](/filings/0001193125-24-258443.md) | [1.0 d](/filings/0001193125-25-054907.md) | [1.1](/filings/0001193125-25-116724.md) | [1.0](/filings/0001193125-25-176488.md) | [(1.1)](/filings/0001193125-25-272371.md) | [1.6 d](/filings/0001193125-26-106151.md) | [1.5](/filings/0001193125-26-214214.md) | [(0.1)](/filings/0001193125-26-339937.md) | [1.8](/filings/0001193125-25-272371.md) | [1.8 d](/filings/0001193125-26-106151.md) | [1.8](/filings/0001193125-26-214214.md) | [2.1](/filings/0001193125-26-339937.md) |
| Net income | $m | [7.6](/filings/0001193125-24-258443.md) | [5.3 d](/filings/0001193125-25-054907.md) | [4.3](/filings/0001193125-25-116724.md) | [5.1](/filings/0001193125-25-176488.md) | [(4.5)](/filings/0001193125-25-272371.md) | [5.2 d](/filings/0001193125-26-106151.md) | [5.4](/filings/0001193125-26-214214.md) | [0.7](/filings/0001193125-26-339937.md) | [6.5](/filings/0001193125-25-272371.md) | [6.1 d](/filings/0001193125-26-106151.md) | [6.2](/filings/0001193125-26-214214.md) | [7.1](/filings/0001193125-26-339937.md) |
| Diluted EPS | $ per share | [1.19](/filings/0001193125-24-258443.md) | not reported | [0.68](/filings/0001193125-25-116724.md) | [0.80](/filings/0001193125-25-176488.md) | [(0.68)](/filings/0001193125-25-272371.md) | not reported | [0.77](/filings/0001193125-26-214214.md) | [0.10](/filings/0001193125-26-339937.md) | [0.95](/filings/0001193125-25-272371.md) | not reported | [0.91](/filings/0001193125-26-214214.md) | [1.04](/filings/0001193125-26-339937.md) |
| Basic EPS | $ per share | [1.21](/filings/0001193125-24-258443.md) | not reported | [0.69](/filings/0001193125-25-116724.md) | [0.81](/filings/0001193125-25-176488.md) | [(0.68)](/filings/0001193125-25-272371.md) | not reported | [0.78](/filings/0001193125-26-214214.md) | [0.10](/filings/0001193125-26-339937.md) | [0.95](/filings/0001193125-25-272371.md) | not reported | [0.92](/filings/0001193125-26-214214.md) | [1.04](/filings/0001193125-26-339937.md) |

- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Total assets | $m | [1,913](/filings/0001193125-23-275720.md) | [1,916](/filings/0001193125-25-054907.md) | [1,988](/filings/0001193125-24-138317.md) | [1,984](/filings/0001193125-24-198936.md) | [2,355](/filings/0001193125-24-258443.md) | [2,340](/filings/0001193125-26-106151.md) | [2,318](/filings/0001193125-25-116724.md) | [2,242](/filings/0001193125-25-176488.md) | [2,229](/filings/0001193125-25-272371.md) | [2,285](/filings/0001193125-26-339937.md) | [2,254](/filings/0001193125-26-214214.md) | [2,251](/filings/0001193125-26-339937.md) |
| Total liabilities | $m | [1,681](/filings/0001193125-23-275720.md) | [1,676](/filings/0001193125-25-054907.md) | [1,746](/filings/0001193125-24-138317.md) | [1,739](/filings/0001193125-24-198936.md) | [2,093](/filings/0001193125-24-258443.md) | [2,078](/filings/0001193125-26-106151.md) | [2,051](/filings/0001193125-25-116724.md) | [1,980](/filings/0001193125-25-176488.md) | [1,962](/filings/0001193125-25-272371.md) | [2,014](/filings/0001193125-26-339937.md) | [1,980](/filings/0001193125-26-214214.md) | [1,971](/filings/0001193125-26-339937.md) |
| Long-term debt | $m | [0.0](/filings/0001193125-23-275720.md) | [0.0](/filings/0001193125-24-076546.md) | not reported | not reported | not reported | [0.0](/filings/0001193125-25-272371.md) | not reported | [10.0](/filings/0001193125-25-176488.md) | [0.0](/filings/0001193125-25-272371.md) | not reported | not reported | not reported |
| Shareholders' equity | $m | [232](/filings/0001193125-24-258443.md) | [240](/filings/0001193125-26-106151.md) | [242](/filings/0001193125-25-176488.md) | [245](/filings/0001193125-25-272371.md) | [262](/filings/0001193125-25-272371.md) | [262](/filings/0001193125-26-339937.md) | [267](/filings/0001193125-26-339937.md) | [262](/filings/0001193125-26-339937.md) | [267](/filings/0001193125-25-272371.md) | [271](/filings/0001193125-26-339937.md) | [274](/filings/0001193125-26-339937.md) | [280](/filings/0001193125-26-339937.md) |

- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [7.3 d](/filings/0001193125-24-258443.md) | [3.0 d](/filings/0001193125-25-054907.md) | [4.8](/filings/0001193125-25-116724.md) | [4.3 d](/filings/0001193125-25-176488.md) | [1.2 d](/filings/0001193125-25-272371.md) | [4.4 d](/filings/0001193125-26-106151.md) | [1.3](/filings/0001193125-26-214214.md) | [3.1 d](/filings/0001193125-26-339937.md) | [4.9 d](/filings/0001193125-25-272371.md) | [12.2 d](/filings/0001193125-26-106151.md) | [5.2](/filings/0001193125-26-214214.md) | [2.6 d](/filings/0001193125-26-339937.md) |
| Capital expenditure | $m | [0.4 d](/filings/0001193125-24-258443.md) | [0.3 d](/filings/0001193125-25-054907.md) | [0.1](/filings/0001193125-25-116724.md) | [0.4 d](/filings/0001193125-25-176488.md) | [0.4 d](/filings/0001193125-25-272371.md) | [0.7 d](/filings/0001193125-26-106151.md) | [0.2](/filings/0001193125-26-214214.md) | [0.3 d](/filings/0001193125-26-339937.md) | [0.2 d](/filings/0001193125-25-272371.md) | [0.2 d](/filings/0001193125-26-106151.md) | [0.3](/filings/0001193125-26-214214.md) | [0.8 d](/filings/0001193125-26-339937.md) |
| Dividends paid | $m | [1.8 d](/filings/0001193125-24-258443.md) | [1.9 d](/filings/0001193125-25-054907.md) | [1.9](/filings/0001193125-25-116724.md) | [1.9 d](/filings/0001193125-25-176488.md) | [1.9 d](/filings/0001193125-25-272371.md) | [2.0 d](/filings/0001193125-26-106151.md) | [2.1](/filings/0001193125-26-214214.md) | [2.1 d](/filings/0001193125-26-339937.md) | [2.1 d](/filings/0001193125-25-272371.md) | [2.4 d](/filings/0001193125-26-106151.md) | [2.5](/filings/0001193125-26-214214.md) | [2.1 d](/filings/0001193125-26-339937.md) |
| Share repurchases | $m | [0.0 d](/filings/0001193125-24-258443.md) | [0.0 d](/filings/0001193125-25-054907.md) | [0.6](/filings/0001193125-25-116724.md) | [0.3 d](/filings/0001193125-25-176488.md) | [0.0 d](/filings/0001193125-25-272371.md) | [0.0 d](/filings/0001193125-26-106151.md) | [0.2](/filings/0001193125-26-214214.md) | [5.5 d](/filings/0001193125-26-339937.md) | [1.9 d](/filings/0001193125-25-272371.md) | [0.3 d](/filings/0001193125-26-106151.md) | [0.1](/filings/0001193125-26-214214.md) | [0.3 d](/filings/0001193125-26-339937.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividends
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | period not labelled (2022-09-30) | Q4 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | thousands of shares | [6.4](/filings/0001193125-23-275720.md) | [6.4](/filings/0001193125-24-138317.md) | [6.4](/filings/0001193125-24-198936.md) | [6.4](/filings/0001193125-24-258443.md) | [6.4](/filings/0001193125-25-116724.md) | [6.4](/filings/0001193125-25-176488.md) | [6,573](/filings/0001193125-25-272371.md) | [6,964](/filings/0001193125-26-214214.md) | [6,896](/filings/0001193125-26-339937.md) | [6,795](/filings/0001193125-25-272371.md) | [6,808](/filings/0001193125-26-214214.md) | [6,823](/filings/0001193125-26-339937.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 6,813,201 at 2026-08-05, from the cover of the [10-Q filed 2026-08-07](/filings/0001193125-26-339937.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:50 ET. No prices; not investment advice.